Asian Institute of Nephrology and Urology 
Dealstreet

Khaitan advises Asian Institute of Nephrology and Urology on sale of majority stake to Asia Healthcare Holdings

The deal amount is valued at ₹600 crore.

Bar & Bench

The Asian Institute of Nephrology and Urology Private Limited ("AINU") has sold the majority stake by way of secondary sale and primary issuance of shares to Asia Healthcare Holdings Pte. Ltd. for an overall deal value of ₹600 crore.

Khaitan & Co advised AINU, the selling shareholders (including the promoters) and the exiting fund, HealthQuad Fund I in this transaction.

The core team consisted of Mayank Singh (Partner), Kevin Peter (Counsel), Kairavi Shah (Principal Associate), Esha Chauhan (Senior Associate), Hitakshi Mahendru (Senior Associate) with closing assistance from Mohnish Singh (Associate).

Mayank Singh

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Vantara: What the SIT's sealed cover report in Supreme Court said

Indian judiciary took time to adopt hands-off approach to arbitration, but got there: Justice N Kotiswar Singh

Entire Himalayan range facing issues: Supreme Court on floods, landslides in north India

We sympathise but move Gujarat HC: Supreme Court on plea alleging custodial torture of minor

Supreme Court tells UGC to frame anti caste-discrimination rules for universities in 2 months

SCROLL FOR NEXT